fNIRS equipment coordinates. by Xinyu Dai (5100731)

“…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”

Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

“…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”

Analysis of variance of CR10. by Xinyu Dai (5100731)

“…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”

Placement on the forehead. by Xinyu Dai (5100731)

“…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”

IMW intervention plan design. by Xinyu Dai (5100731)

“…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”

Neuropsychological Test Measures. by Michael R. Lawrence (21369854)

“…Serum levels of nerve growth factor (NGF), a biomarker of brain plasticity, were significantly lower in the long COVID group, which was significantly more likely than controls to have serum levels of inflammatory marker (interleukin (IL)-10) values greater than or equal to the median (p = 0.015). …”

Dataset. Dataset. by Michael R. Lawrence (21369854)

“…Serum levels of nerve growth factor (NGF), a biomarker of brain plasticity, were significantly lower in the long COVID group, which was significantly more likely than controls to have serum levels of inflammatory marker (interleukin (IL)-10) values greater than or equal to the median (p = 0.015). …”

Self-Report Questionnaires. by Michael R. Lawrence (21369854)

“…Serum levels of nerve growth factor (NGF), a biomarker of brain plasticity, were significantly lower in the long COVID group, which was significantly more likely than controls to have serum levels of inflammatory marker (interleukin (IL)-10) values greater than or equal to the median (p = 0.015). …”

Table 1_Efficacy and safety of combination of frankincense and botulinum toxin in the treatment of blepharospasm: a protocol for a single-centre, open-label, randomized, controlled... by Shiyuan Gong (22754579)

“…Symptom improvement is defined as a decrease of one point or more in the Jankovic Rating Scale severity score compared to baseline in patients with BSP. …”

Original values used to build graphs. by Min Qin (123347)

“…The m⁶A-IP-qPCR assay further confirmed that <i>T. gondii</i> infection led to the decrease in the levels of m⁶A modification in the 3’UTR and 5’UTR regions of <i>TNF-α</i> mRNA. …”

Table 1_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

“…Within group HS, IC-related dACC activity was greater among individuals reporting less intense (b-95 CI = [−0.201, −0.041], p = 0.004) and less frequent alcohol craving experiences (b-95 CI = [−0.131, 0.005], p = 0.068), whereas in group LS, IC-related dACC activity was greater among individuals reporting more intense (b-95 CI = [0.009, 0.140], p = 0.028) and more frequent alcohol craving experiences (b-95 CI = [0.022, 0.128], p = 0.007).…”

Table 2_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

“…Within group HS, IC-related dACC activity was greater among individuals reporting less intense (b-95 CI = [−0.201, −0.041], p = 0.004) and less frequent alcohol craving experiences (b-95 CI = [−0.131, 0.005], p = 0.068), whereas in group LS, IC-related dACC activity was greater among individuals reporting more intense (b-95 CI = [0.009, 0.140], p = 0.028) and more frequent alcohol craving experiences (b-95 CI = [0.022, 0.128], p = 0.007).…”

Illustrative examples of our study. by Mustafa Tuşat (21094179)

Statistical table of differential metabolites. by Wanyan Li (9741989)

“…PAMK was administered to goslings following LPS-induced intestinal injury, and its effects were assessed. PAMK significantly reduced the serum levels of inflammatory factors including interleukin (IL)-6 and C-reactive protein and decreased the expression of pro-inflammatory cytokines including interleukin(IL)-1, IL-6, and toll-like receptor 2 in jejunal tissues. …”

The metabolic differences between P-LPS and LPS. by Wanyan Li (9741989)

“…PAMK was administered to goslings following LPS-induced intestinal injury, and its effects were assessed. PAMK significantly reduced the serum levels of inflammatory factors including interleukin (IL)-6 and C-reactive protein and decreased the expression of pro-inflammatory cytokines including interleukin(IL)-1, IL-6, and toll-like receptor 2 in jejunal tissues. …”

Eight weeks of prophylactic <i>Lactobacillus plantarum</i> KAD supplementation protects mice against colonic permeability, oxidative stress, histological abnormalities. by Supriyo Ghosh (18160523)

Primer sequence. by Wanyan Li (9741989)

“…PAMK was administered to goslings following LPS-induced intestinal injury, and its effects were assessed. PAMK significantly reduced the serum levels of inflammatory factors including interleukin (IL)-6 and C-reactive protein and decreased the expression of pro-inflammatory cytokines including interleukin(IL)-1, IL-6, and toll-like receptor 2 in jejunal tissues. …”

Global trends of SAH in AYAs from 1990 to 2021. by Xuanchen Liu (12188147)

“…Particularly, the ASIR showed a continuous decline from 1990 to 2015, followed by a slight increase from 2014 to 2019 (APC: 0.14%, 95% CI: 0.03, 0.25), and accelerated growth from 2019 to 2021 (APC: 1.23%, 95% CI: 0.88, 1.57). …”

Experimental setup. by Shinnosuke Hase (20917896)

“…Conversely, the fast-rhythm auditory guide significantly increased step rate and decreased step length (p <  0.05). …”

Table 1_A study of the adjunctive therapeutic effects of a 3-week bamboo forest therapy on chronic diseases in the elderly.docx by Jing He (58446)

“…Diabetic participants showed significant decreases in fasting and pre-bedtime blood glucose levels (p < 0.001), along with reduced blood glucose fluctuations post-meal. …”